| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 37, 269-272, Copyright © 1991 by American Association for Clinical Chemistry
A Tanaka, H Ishii, S Hiraishi, M Kazama and H Maezawa
Third Department of Internal Medicine, School of Medicine, Tokyo Medical and Dental University, Japan.
To study the significance of plasma thrombomodulin (TM) values in diabetes mellitus, we determined plasma TM in 34 patients with non- insulin-dependent diabetes mellitus (NIDDM) men, mean age 54 (SE 2) years. Plasma TM was determined by an enzyme immunoassay with anti-TM monoclonal antibodies. The plasma TM values were significantly greater in NIDDM patients with nephropathy than in patients without nephropathy (P less than 0.001). Also, a significant positive correlation was noted between the concentration of plasma TM and serum creatinine (r = 0.55, P less than 0.001). The plasma TM values of the patients with retinopathy were significantly greater than the values of those without it (P less than 0.002). Furthermore, we noted a significant positive correlation (r = 0.78, P less than 0.001) between plasma TM and the severity of diabetic retinopathy as graded by Scott's classification. These results suggest a close relationship between TM and diabetic microangiopathy.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  M. Blank, Y. Shoenfeld, S. Tavor, S. Praprotnik, M. C. Boffa, B. Weksler, M. J. Walenga, J. Amiral, and A. Eldor Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells Int. Immunol., February 1, 2002; 14(2): 121 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Praprotnik, M. Blank, Y. Levy, S. Tavor, M.-C. Boffa, B. Weksler, A. Eldor, and Y. Shoenfeld Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells Int. Immunol., February 1, 2001; 13(2): 203 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Randi, C. Meneghin, P. Zerbinati, A. Sbarai, E. Rampin, R. Pasini, L. Zanin, A. Girolami, and G. Cella Soluble Plasma Thrombomodulin Levels in Patients with Chronic Myeloproliferative Disorder Clinical and Applied Thrombosis/Hemostasis, January 1, 1999; 5(1): 43 - 47. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Fujieda, N. Oishi, K. Naruse, M. Hashizume, K. Nishiya, T. Kurashige, and K. Ito Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schonlein purpura Arch. Dis. Child., March 1, 1998; 78(3): 240 - 244. [Abstract] [Full Text]
|
|
|
|
 |
|
 M-C. Boffa and M. Karmochkine Review : Thrombomodulin: an overview and potential implications in vascular disorders Lupus, January 1, 1998; 7(2_suppl): S120 - S125. [Abstract] [PDF]
|
|
|
|
 |
|
 J.-H. Jansson, K. Boman, M. Brannstrom, and T. K. Nilsson High Concentration of Thrombomodulin in Plasma Is Associated With Hemorrhage : A Prospective Study in Patients Receiving Long-term Anticoagulant Treatment Circulation, November 4, 1997; 96(9): 2938 - 2943. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. V. Sakharov, E. F. Plow, and D. C. Rijken On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase B J. Biol. Chem., May 30, 1997; 272(22): 14477 - 14482. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
